Valuation Roche Holding AG

Stocks

End-of-day quote Swiss Exchange Other stock markets 2026-06-05			5-day change	1st Jan Change
327.10 ^CHF	+0.77%		0.00%	-0.34%

Jun. 12	Roche Receives FDA Approval for the First Companion Diagnostic to Assess PTEN Protein in People Living with Prostate Cancer	CI
Jun. 12	Jazz Pharmaceuticals lung cancer drug fails main trial goal	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	306,810	239,812	197,073	205,191	262,098	262,981	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	0.34%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	273,294	266,419	258,483
Change	-	-21.41%	-15.51%	3.13%	25.04%	-1.78%	-2.52%	-2.98%
P/E Ratio	23.4x	18.9x	17.1x	24.8x	20.5x	17.7x	16.5x	15.2x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	6.52x	5.51x	4.68x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1.1x	2.23x	1.74x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.2x	4.04x	3.85x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.37x	4.09x	3.78x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	10.7x	9.79x	8.95x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	12.1x	11x	10x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	17.1x	15.8x	14.2x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.83%	6.32%	7.06%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.03	10.28	10.56
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	3.04%	3.11%	3.2%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.64	20.02	21.76
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	53.8%	51.3%	48.5%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,581	65,133	68,351
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,465	27,203	28,889
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,565	24,231	25,827
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,156	16,221	17,488
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,313	3,438	-4,498
Reference price ²	379.10	290.50	244.50	255.50	328.20	330.00	330.00	330.00
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	2/3/22	2/2/23	2/1/24	1/30/25	1/29/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ROCHE HOLDING AG	17.71x	4.37x	10.73x	3.04%	330B
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,010B
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	580B
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	402B
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	281B
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	280B
NOVO NORDISK A/S	12.7x	4.76x	9.73x	3.95%	197B
AMGEN INC.	23.09x	6.16x	10.76x	2.84%	192B
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	156B
PFIZER INC.	12.26x	3.2x	7.8x	6.68%	149B
Average	15.16x	5.89x	15.06x	2.97%	357.83B
Weighted average by Cap.	22.24x	7.29x	17.01x	2.28%